4//SEC Filing
Clark Eliana 4
Accession 0001209191-23-041495
CIK 0001652130other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 3:34 PM ET
Size
5.3 KB
Accession
0001209191-23-041495
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2023-07-03$40.51/sh−360$14,584→ 45,146 total
Footnotes (2)
- [F1]Sale of 360 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.51 to $40.52, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001914448
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 3:34 PM ET
- Size
- 5.3 KB